Weekly Digest – August 2025 Weekly Digest – August 2025 26 August 2025: Genmab receives FDA Breakthrough Therapy Designation for Rinatabart sesutecan (Rina-S) in advanced endometrial cancer (EC) The FDA granted Breakthrough Therapy Designation to Genmab’s rinatabart sesutecan (Rina-S) for […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id